Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0403608 (
ureter
)
9,655
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several in vitro studies have shown that
cyclin A
gene alteration in the cell cycle plays an important role in carcinogenesis. We immunohistochemically examined the expression of
cyclin A
protein in 120 patients with transitional cell carcinoma (TCC) of the renal pelvis and
ureter
, including adjacent dysplastic lesions to determine their significance for the tumor behavior and patient prognosis. Cyclin A immunostaining of the nucleus was observed in 29 tumors (24.2%). Furthermore, 17
cyclin A
-positive tumors (58.6%) had dysplastic lesions positive for
cyclin A
antibody. The prevalence of cases exhibiting
cyclin A
staining was higher in the high grade (P < 0.01) and invasive tumors (P < 0.05) than in the other types of tumors. In the selected 117 cases, patients whose TCCs expressed a high level of
cyclin A
protein had a significantly poorer prognosis than those without
cyclin A
expression (P < 0.01). These in vivo findings provide the first evidence for frequent and redundant
cyclin A
protein overexpression in TCC and suggest that
cyclin A
overexpression is related to the tumor behavior and patient prognosis. In addition, our observations indicate that overexpression of
cyclin A
may be one of the early events, at least in some cases, in the carcinogenesis of TCC.
...
PMID:Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis. 981 24